loading

Alzamend Neuro Inc Azioni (ALZN) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-07-31 2025-04-30 2025-01-31 2024-10-31 2024-07-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
137.08%
2.7002
1.1389 1.0374 1.3581 0.9624
Interest Income/Expense
387.82%
0.00248
0.000509 0.00202 0.0035 0.012
Operating Income/Loss
137.08%
-2.7002
-1.1389 -1.0374 -1.3581 -0.9624
Nonoperating Income/Loss
387.82%
-0.00248
-0.000509 -0.00202 -0.0035 -0.012
Income/Loss From Continuing Operations Before Tax
336.96%
2.70
-1.1394 -1.0394 -1.3616 1.00
Income/Loss From Continuing Operations After Tax
336.96%
2.70
-1.1394 -1.0394 -1.3616 1.00
Net Income/Loss
65.72%
2.70
7.8754 -1.0394 -1.3616 1.00
Preferred Stock Dividends And Other Adjustments
100.00%
-
0.5902 - - -
Attributable To Noncontrolling Interest
40.07%
5.4027
9.0149 - 0.0537 1.9744
Basic Average Shares
174.55%
2.106
-2.825 5.5178 3.5317 0.7778
Diluted Average Shares
174.55%
2.106
-2.825 5.5178 3.5317 0.7778
Basic Earnings Per Share
87.56%
-1.28
-10.29 -0.19 -0.40 -1.25
Diluted Earnings Per Share
87.56%
-1.28
-10.29 -0.19 -0.40 -1.25
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
100.00%
-
0.5902 - - -
$28.50
price up icon 0.78%
$50.76
price up icon 2.57%
$92.69
price down icon 3.01%
$138.73
price down icon 1.11%
$147.88
price down icon 0.02%
ONC ONC
$305.60
price up icon 2.86%
Capitalizzazione:     |  Volume (24 ore):